PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Bacterium infecting cystic fibrosis patients genetically evolves to live in lungs and evade antibiotic treatments

Research by University of Ottawa and University of Calgary scientists opens the door to more effective treatments for life-threatening disease

2013-12-12
(Press-News.org) Contact information: Marie-Helene Thibeault
m.thibeault@ucalgary.ca
403-679-8447
University of Calgary
Bacterium infecting cystic fibrosis patients genetically evolves to live in lungs and evade antibiotic treatments Research by University of Ottawa and University of Calgary scientists opens the door to more effective treatments for life-threatening disease

The bacterium that's the most important pathogen in patients with cystic fibrosis (CF) has genetically evolved and adapted to survive in CF-infected lungs and evade antibiotic treatments, scientists from the University of Ottawa and the University of Calgary have shown.

Pseudomonas aeruginosa is called an "opportunistic pathogen." While the microorganism is widespread in the environment and is harmless to healthy people, it infects those who are ill or have compromised immune systems.

The team of scientists performed the first systematic analysis of entire genomes (the full genetic 'blueprint') for multiple "epidemic and nonepidemic" strains of P. aeruginosa.

Their analysis showed that the main drivers for the evolution and adaptation of the bacterium are the CF-lung environment itself and the presence of antibiotics.

"Many of the genes and pathways implicated in adaptive evolution within the host had obvious roles in the pathogenic lifestyle of this bacteria," says their study, published this week in the Proceedings of the National Academic of Sciences of the United States of America.

Lead author is Jeremy R. Dettman, from the Centre for Advanced Research in Environmental Genomics at the University of Ottawa.

Better understanding of how the pathogen evolves will help advance more effective treatments for infected cystic fibrosis patients, says co-author Nicolas Rodrigue, University of Calgary professor of statistics in the Department of Mathematics and Statistics in the Faculty of Science.

"If we can devise a multi-pronged treatment approach that addresses all or most of the different ways that the bacteria can adapt to different treatments, then the bacteria will be out of luck," Rodrigue says.

Approximately 4,000 people have cystic fibrosis in Canada, and one person in the country dies from the disease each week, according to Cystic Fibrosis Canada.

The unique aspect of the new study is that "we looked at a large number of strains. Instead of looking at just a few genes here and there, we looked at the entire genomes of all these 32 strains," Rodrigue says.

The scientists also found that an epidemic strain of P. aeruginosa has spread between clinics in the United Kingdom and North America – likely through international air travel.

As a statistician, Rodrigue's key role was to devise and implement the computational and statistical approaches used to analyze a massive amount of data.

He used computer programs – including some he wrote himself – to assemble "millions of little snippets" of DNA into the genomes for each bacterial strain. "It's like a huge jigsaw puzzle that we have to put together," he says.

Rodrigue also performed a "statistical inference of the evolutionary relationships" among all 32 strains. This included identifying which genes had been gained or lost during evolution, which underwent genetic recombination and which were the target of selection.

Rodrigue, who joined the University of Calgary in September, says a multidisciplinary research approach increasingly will be needed given the growing richness of scientific data. "Statisticians will have to know a lot about the science in which they're working. And the scientists are going to have to become more statistically sophisticated and knowledgeable."



INFORMATION:



The study received financial support from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research.



ELSE PRESS RELEASES FROM THIS DATE:

Breast cancer treatment selection is improved by genomic tests at Jefferson Breast Care Center

2013-12-12
Breast cancer treatment selection is improved by genomic tests at Jefferson Breast Care Center Molecular subtyping enables more accurate prognosis and treatment selection, according to research presented at San Antonio conference ...

Neuroscience method of optogenetics as good as electrical stimulation

2013-12-12
Neuroscience method of optogenetics as good as electrical stimulation PROVIDENCE, R.I. [Brown University] — Neuroscientists are eagerly, but not always successfully, looking for proof that optogenetics – a celebrated technique that uses pulses of visible light ...

PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant

2013-12-12
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant SAN ANTONIO — Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery ...

Exercise improves drug-associated joint pain in breast cancer survivors

2013-12-12
Exercise improves drug-associated joint pain in breast cancer survivors SAN ANTONIO — Breast cancer survivors taking aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane experienced a reduction in joint pain if they exercised ...

New drug combination delayed disease progression for subgroup of women with metastatic breast cancer

2013-12-12
New drug combination delayed disease progression for subgroup of women with metastatic breast cancer SAN ANTONIO — Adding the drug dasatinib to a standard antihormone therapy, letrozole, doubled the time before disease progressed for women with ...

Antihormone therapy anastrozole may provide new option for breast cancer prevention

2013-12-12
Antihormone therapy anastrozole may provide new option for breast cancer prevention SAN ANTONIO — Breast cancer incidence among postmenopausal women at high risk for developing the disease was significantly reduced by the antihormone therapy ...

Combining mutants results in 5-fold lifespan extension in C. elegans

2013-12-12
Combining mutants results in 5-fold lifespan extension in C. elegans Research highlights possibility of combination therapy for aging What are the limits to longevity? New research in simple animals suggests that combining mutants can lead to radical ...

Temple scientists studying mitochondrial calcium handling yield new disease targets

2013-12-12
Temple scientists studying mitochondrial calcium handling yield new disease targets (Philadelphia, PA) – When things go wrong, cells turn to built-in safety mechanisms for survival. One of those mechanisms involves calcium uptake by mitochondria, ...

Partially blocking blood vessels' energy source may stop cancer growth, blindness & other conditions

2013-12-12
Partially blocking blood vessels' energy source may stop cancer growth, blindness & other conditions VIDEO: This is a confocal time-lapse video imaging of a control (A; DMSO) ...

Surprise: Duck-billed dinosaurs had fleshy 'cocks comb'

2013-12-12
Surprise: Duck-billed dinosaurs had fleshy 'cocks comb' A rare, mummified specimen of the duck-billed dinosaur Edmontosauraus regalis described in the Cell Press journal Current Biology on December 12 shows for the first time that those dinosaurs' heads were adorned with a ...

LAST 30 PRESS RELEASES:

Hallucinogen use linked to 2.6-fold increase in risk of death for people needing emergency care

Pathogenicity threshold of SCA6 causative gene CACNA1A was identified

Mysterious interstellar icy objects

Chronic diseases misdiagnosed as psychosomatic can lead to long term damage to physical and mental wellbeing, study finds

Omalizumab treats multi-food allergy better than oral immunotherapy

Sleep apnea linked to increased risk of Parkinson’s, but CPAP may reduce risk

New insights into drug addiction: The role of astrocytic G protein-coupled receptors

Digital twin technology: Transforming road engineering and its lifecycle applications

Next-generation AI and big data: Transforming crop breeding

Biomimetic synthesis of natural products: Progress, challenges and prospects

New limits found for dark matter properties from latest search

SCAI expresses disappointment over ABMS decision to deny independent cardiovascular medicine boar

Rice researchers develop efficient lithium extraction method, setting stage for sustainable EV battery supply chains

Statement on ABMS denying new cardiovascular board

St. Jude scientists solve mystery of how the drug retinoic acid works to treat neuroblastoma

New device could allow you to taste a cake in virtual reality

Illinois researchers develop next-generation organic nanozymes and point-of-use system for food and agricultural uses

Kicking yourself: Going against one’s better judgment amplifies self-blame

Rice researchers harness gravity to create low-cost device for rapid cell analysis

Revolutionary copper-infused microvesicles: a new era in biofunctional medicine

Primary care practices with NPs are key to increasing health care access in less advantaged areas, Columbia Nursing study shows

TTUHSC conducting study to help patients that experience traumatic blood loss

Next top model: Competition-based AI study aims to lower data center costs

Innovative startup awarded $10,000 to tackle cardiovascular disparities

Study compares indoor transmission-risk metrics for infectious diseases

Micro-expression detection in ASD movies: a YOLOv8-SMART approach

Machine learning on blockchain: A new approach to engineering computational security

Vacuum glazing: A promising solution for low-carbon buildings

Racial and ethnic differences in out-of-pocket spending for maternity care

Study reveals racial and ethnic disparities in maternity care spending

[Press-News.org] Bacterium infecting cystic fibrosis patients genetically evolves to live in lungs and evade antibiotic treatments
Research by University of Ottawa and University of Calgary scientists opens the door to more effective treatments for life-threatening disease